For instance, CCR1, CCR7, or CXCR4 modification was found to enhance the migration of MSCs to the injured myocardium [42], secondary lymphoid organs [43], and infarcted myocardium [44, 45], respectively, and to promote recovery in animal disease models. This evidence concerns the gene CXCR4 and non-human animal disease.